.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
DEFUSE 3 provided complementary randomized evidence that selected patients with anterior-circulation large-vessel occlusion can benefit from thrombectomy well beyond the traditional early treatment window. Participants presenting between six and 16 hours from last known well were selected using imaging criteria designed to identify a small infarct core with substantial potentially salvageable tissue. Thrombectomy plus standard medical treatment resulted in a marked improvement in functional outcomes compared with medical therapy alone and reduced mortality. The study is particularly important because it used physiological tissue selection rather than time alone to identify likely treatment responders. For HCPs, the clinical implication is that stroke systems need rapid access to advanced imaging and clear pathways for transfer of eligible patients. The study also reinforces the importance of avoiding therapeutic nihilism in wake-up or late-presenting stroke. At the same time, the results should be applied to patients who match the trial's vascular, clinical and imaging profile. The evidence contributes directly to IANCON's focus on advanced stroke intervention and the boundaries of endovascular treatment.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
DEFUSE 3 provided complementary randomized evidence that selected patients with anterior-circulation large-vessel occlusion can benefit from thrombectomy well beyond the traditional early treatment window. Participants presenting between six and 16 hours from last known well were selected using imaging criteria designed to identify a small infarct core with substantial potentially salvageable tissue. Thrombectomy plus standard medical treatment resulted in a marked improvement in functional outcomes compared with medical therapy alone and reduced mortality. The study is particularly important because it used physiological tissue selection rather than time alone to identify likely treatment responders. For HCPs, the clinical implication is that stroke systems need rapid access to advanced imaging and clear pathways for transfer of eligible patients. The study also reinforces the importance of avoiding therapeutic nihilism in wake-up or late-presenting stroke. At the same time, the results should be applied to patients who match the trial's vascular, clinical and imaging profile. The evidence contributes directly to IANCON's focus on advanced stroke intervention and the boundaries of endovascular treatment.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
